Literature DB >> 14635724

CoMFA and docking study of novel estrogen receptor subtype selective ligands.

Peter Wolohan1, David E Reichert.   

Abstract

We present the results from a Comparative Molecular Field Analysis (CoMFA) and docking study of a diverse set of 36 estrogen receptor ligands whose relative binding affinities (RBA) with respect to 17beta-Estradiol were available in both isoforms of the nuclear estrogen receptors (ER alpha, ER beta). Initial CoMFA models exhibited a correlation between the experimental relative binding affinities and the molecular steric and electrostatic fields; ER alpha: r2 = 0.79, q2 = 0.44 ER beta: r2 = 0.93, q2 = 0.63. Addition of the solvation energy of the isolated ligand improved the predictive nature of the ER beta model initially; r2 = 0.96, q2 = 0.70 but upon rescrambling of the data-set and reselecting the training set at random, inclusion of the ligand solvation energy was found to have little effect on the predictive nature of the CoMFA models. The ligands were then docked inside the ligand binding domain (LBD) of both ER alpha and ER beta utilizing the docking program Gold, after-which the program CScore was used to rank the resulting poses. Inclusion of both the Gold and CScore scoring parameters failed to improve the predictive ability of the original CoMFA models. The subtype selectivity expressed as RBA(ER alpha/ER beta) of the test sets was predicted using the most predictive CoMFA models, as illustrated by the cross-validated r2. In each case the most selective ligands were ranked correctly illustrating the utility of this method as a prescreening tool in the development of novel estrogen receptor subtype selective ligands.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14635724     DOI: 10.1023/a:1026104924132

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  34 in total

1.  Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins.

Authors:  P S Charifson; J J Corkery; M A Murcko; W P Walters
Journal:  J Med Chem       Date:  1999-12-16       Impact factor: 7.446

2.  Comparative QSAR analysis of estrogen receptor ligands.

Authors:  H Gao; J A Katzenellenbogen; R Garg; C Hansch
Journal:  Chem Rev       Date:  1999-03-10       Impact factor: 60.622

3.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

4.  Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design.

Authors:  C Pérez; M Pastor; A R Ortiz; F Gago
Journal:  J Med Chem       Date:  1998-03-12       Impact factor: 7.446

5.  ER beta: identification and characterization of a novel human estrogen receptor.

Authors:  S Mosselman; J Polman; R Dijkema
Journal:  FEBS Lett       Date:  1996-08-19       Impact factor: 4.124

6.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

Authors:  K Paech; P Webb; G G Kuiper; S Nilsson; J Gustafsson; P J Kushner; T S Scanlan
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

7.  Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists.

Authors:  S R Stauffer; C J Coletta; R Tedesco; G Nishiguchi; K Carlson; J Sun; B S Katzenellenbogen; J A Katzenellenbogen
Journal:  J Med Chem       Date:  2000-12-28       Impact factor: 7.446

8.  A new method for predicting binding affinity in computer-aided drug design.

Authors:  J Aqvist; C Medina; J E Samuelsson
Journal:  Protein Eng       Date:  1994-03

9.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.

Authors:  G Jones; P Willett; R C Glen
Journal:  J Mol Biol       Date:  1995-01-06       Impact factor: 5.469

10.  3D-QSAR methods on the basis of ligand-receptor complexes. Application of COMBINE and GRID/GOLPE methodologies to a series of CYP1A2 ligands.

Authors:  J J Lozano; M Pastor; G Cruciani; K Gaedt; N B Centeno; F Gago; F Sanz
Journal:  J Comput Aided Mol Des       Date:  2000-05       Impact factor: 3.686

View more
  7 in total

1.  Multiple-targeting and conformational selection in the estrogen receptor: computation and experiment.

Authors:  Peng Yuan; Kaiwei Liang; Buyong Ma; Nan Zheng; Ruth Nussinov; Jian Huang
Journal:  Chem Biol Drug Des       Date:  2011-04-27       Impact factor: 2.817

Review 2.  CoMSIA and docking study of rhenium based estrogen receptor ligand analogs.

Authors:  Peter Wolohan; David E Reichert
Journal:  Steroids       Date:  2007-02-05       Impact factor: 2.668

Review 3.  Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation.

Authors:  Kenneth A Krohn; David R Vera
Journal:  Nucl Med Biol       Date:  2020-03-12       Impact factor: 2.408

4.  In silico prediction of estrogen receptor subtype binding affinity and selectivity using statistical methods and molecular docking with 2-arylnaphthalenes and 2-arylquinolines.

Authors:  Zhizhong Wang; Yan Li; Chunzhi Ai; Yonghua Wang
Journal:  Int J Mol Sci       Date:  2010-09-20       Impact factor: 5.923

5.  Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists.

Authors:  Hui Wen Ng; Wenqian Zhang; Mao Shu; Heng Luo; Weigong Ge; Roger Perkins; Weida Tong; Huixiao Hong
Journal:  BMC Bioinformatics       Date:  2014-10-21       Impact factor: 3.169

6.  Computational study of estrogen receptor-alpha antagonist with three-dimensional quantitative structure-activity relationship, support vector regression, and linear regression methods.

Authors:  Ying-Hsin Chang; Jun-Yan Chen; Chiou-Yi Hor; Yu-Chung Chuang; Chang-Biau Yang; Chia-Ning Yang
Journal:  Int J Med Chem       Date:  2013-05-14

7.  A QSAR study of environmental estrogens based on a novel variable selection method.

Authors:  Zhongsheng Yi; Aiqian Zhang
Journal:  Molecules       Date:  2012-05-21       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.